TGFB1 and neoplasm: In later stages, epithelial cells become refractory to the growth inhibitory effect of TGF-β and begin to secrete high levels of TGF-β, which in turn exhibits tumor-promoting activity, such as angiogenesis, immune evasion, fibroblast activation, and ECM accumulation [6–8].